(AOF) – Vetoquinol publishes a net result of 32 million euros in the first half, or 12.6% of turnover, an increase of 50.6% compared to the end of June 2022. The laboratory specializing in veterinary products intended for pets highlights that its turnover of 256 million euros, for the first 6 months of the financial year, is down 5.4% based on published data and -4.6% at constant exchange rates. . EBITDA stood at 60 million euros as of June 30, 2023, or 23.3% of turnover.
“In a global animal health market driven by prices, our first half of 2023 is marked on the one hand by a decline in our activity and on the other hand by maintaining a solid level of our profitability and a good generation of cash”, declares Matthieu Frechin, Chairman and CEO.
“The agility and mobilization of our teams as well as the evolution of our product mix over more than 10 years, at a time when our Vetoquinol laboratory is celebrating its 90th anniversary, allow us to anticipate a better second half of 2023.”
© 2023 Agence Option Finance (AOF) – All rights reserved by AOF. AOF collects its data from the sources it considers the most reliable. However, the reader remains solely responsible for their interpretation and for the use of the information made available to them. Thus the reader must hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends with the buttons below.
